JPRN-UMIN000007990已完成2 期
A phase II study of first line chemotherapy by eribulin mesilate for HER2 negative recurrent breast cancer - KBCOG 11
Kobe Breast Cancer Oncology Group0 个研究点目标入组 35 人开始时间: 2012年5月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) serious complication or past history: with symptomatic heart failure, liver cirrhosis, psychological disorder treated by antipsychotic drug, ischemic heart disease within 6 months, etc 2) active infection 3) peripheral neuropathy greater than Grade 3 4) male breast cancer 5) pregnant or nursing women, women who like be pregnant 6) with doctors decision for exclusion
研究者
相似试验
已完成
2 期
A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancerStage lb2 lla cervical cancer with pelvic lymph node metastasisJPRN-UMIN000003036Japanese Gynecologic Oncology Group63
招募中
2 期
Phase II study of elental for chemotherapy induced mucositis oral and nutritional disturbanceJPRN-UMIN000009298Aizawa Hospital30
已完成
不适用
Phase II study of second-line chemotherapy using modified FOLFOX6 in patients with advanced/ recurrent colorectal cancer (OGSG 0505)Patients with unresectable or metastatic colon cancer registant to fluorouracil treatmentJPRN-UMIN000000841OGSG50
已完成
1 期
Phase I study of combination chemotherapy with irinotecan hydrochroride(CPT-11) and nedaplatin(NDP) for locally advanced stage Ib2-IVa cervical cancer after Concurrent chemoradiotherapy (CCRT)Stage Ib2-IVa cervical cancerJPRN-UMIN000007458Japanese Gynecologic Oncology Group48
已完成
不适用
Phase II study of concurrent chemotherapy with itraconazole in advanced gynecologic tumors.Gynecologic cancerJPRN-UMIN000013951Department of Obstetrics and Gynecology, Hyogo College of Medicine16